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Mammalian voltage-gated K channels are assemblies
of pore-forming -subunits and modulating -subunits.
To operate correctly, Kv4 -subunits in the heart and
central nervous system require recently identified
-subunits of the neuronal calcium sensing protein fam-
ily called K channel-interacting proteins (KChIPs).
Here, Kv4.2KChIP2 channels are purified, integrity of
isolated complexes confirmed, molar ratio of the sub-
units determined, and subunit valence established. A
complex has 4 subunits of each type, a stoichiometry
expected for other channels employing neuronal cal-
cium sensing -subunits.
In muscles and nerves, Kv4 (Shal family) -subunits assem-
ble with K channel-interacting proteins (KChIPs)1 -subunits
to create mixed complexes with unique attributes and functions
(1–7). Thus, Kv4 channels produce rapidly activating and in-
activating currents, such as Ito, which mediates the early re-
polarization phase of the cardiac action potential (8–11), and
IA, to regulate action potential propagation and frequency in
neurons (12–14). KChIP subunits 1–4 enjoy differential tissue
distribution, splice variation and carry EF-hand motifs as do
other neuronal calcium sensing peptides (including frequenin,
recoverin, guanylyl cyclase activating protein, and the visinin-
like proteins visinin-like proteins 1–3, neurocalcin, and hip-
pocalcin) (15); the roles of visinin-like proteins are now
emerging.
KChIPs (and frequenin) (16, 17) have been shown to assem-
ble with Kv4 subunits in stable fashion leading to increased
current density due to enhanced surface expression, activation
at more hyperpolarized potentials, slowed inactivation, and
speeded recovery from inactivation (1, 2, 16). These -subunits
permit kinase regulation (18), control trafficking, and alter
surface half-life (6). So, the increase in Ito across canine cardiac
ventricular wall (from endo- to epicardium) reflects a parallel
gradient in KChIP2 expression (3), and transgenic mice devoid
of KChIP2 have no measurable Ito, a prolonged action poten-
tial, and susceptibility to ventricular arrhythmia (4).
Functional and structural studies of -subunits demonstrate
that K channel conduction pores are formed by assembly of 4
pore loops about a central axis (19). Conversely, K channel
accessory subunits vary in their nature (soluble, peripheral, or
membrane-spanning) and number per complex (20). To explore
the structural basis for KChIP function, the stoichiometry of
Kv4.2KChIP2 channels was determined using a stepwise
strategy: significant amounts of intact, functional Kv4.2
KChIP2 complexes were produced and isolated; functional and
structural integrity of the purified material was confirmed by a
toxin binding assay; and, thereafter, subunit valence was es-
tablished by gradient centrifugation and direct amino acid
analysis.
MATERIALS AND METHODS
Molecular Biology—Human Kv4.2 and KChIP2 were expressed in
pRAT, a dual purpose vector with a cytomegalovirus promoter for
mammalian expression and a T7 promoter for cRNA synthesis. Charyb-
dotoxin (CTX)-sensitive Kv4.2 (Kv4.2*) was produced by plaque-form-
ing unit-based mutation (Stratagene, La Jolla, CA); the pore segment
containing mutations was isolated with NruI and BamHI and replaced
into a wild-type human Kv4.2 backbone. The 1D4 epitope was intro-
duced by creating an Mlu1 site in place of the termination codon and
inserting a nucleotide compatible to Mlu1 and BglII encoding a linker
and the epitope (RVPDGDPDETSQVAPAX). cRNA was synthesized
after linearization with NotI using an mMessage mMachine kit (Am-
bion, Austin, TX). cRNAs were quantified by spectroscopy and gel
electrophoresis. The gene variants used in this study were human
Kv4.2 (accession number AH009258), KChIP2 (accession number
AF199598), and Kv1.3 (accession number NM_002232).
Electrophysiology and Data Analysis—Oocytes from Xenopus laevis
frogs were defolliculated by collagenase and injected with 0.2 ng of
Kv4.2 or Kv4.2* and 0.4 ng of KChIP2 cRNA. For CTX block studies less
cRNA was injected for mixed complexes so macroscopic current was like
that for -subunits alone. Currents were studied at 12–24 h. Whole-cell
currents were measured by two electrode voltage clamp (Geneclamp
500, Axon Instruments, Union City, CA). Electrodes were filled with 3
M KCl and had resistance of 0.1–1.2 M. Data were sampled at 1 kHz.
Data recording was performed using Clampex v8.0 and assessed with
Clampfit v8.0, Excel, and Origin 6.0. All experiments were performed at
room temperature. Standard bath solution was ND-96: 96 mM NaCl, 2
mM KCl, 1 mM MgCl2, 1.8 mM CaCl2, 5 mM HEPES/NaOH, pH 7.5) and
supplemented with 0.1% bovine serum albumin for CTX studies. CTX
binding kinetics were examined with voltage pulses to 40 mV for 500 ms
from a resting membrane voltage of 80 mV repeated every 20 s.
Current-voltage curves were evoked by depolarizing from a holding
potential of 100 mV to test potentials of 80 to 70 mV with 10 mV
steps lasting 500 ms every 5 s. Steady state inactivation was examined
from a holding potential of 100 mV with test pulses from 120 to 10
mV held for 2.5 s with a second pulse at 40 mV to measure currents that
were not inactivated. Recovery from inactivation was measured by
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driving channels to an inactivated state at 40 mV, hyperpolarizing to
100 mV, and then applying a second pulse to 40 mV for various
intervals (increments of 5 and 50 ms). Inactivation was fit to a double
exponential equation. Recovery from inactivation was fit to a single
exponential. Activation V0.5 and Vs were calculated by fitting the con-
ductance-voltage relationship to a Boltzmann function. Similarly, inac-
tivation V0.5 and Vs were calculated by fitting the normalized current-
voltage relationship to a Boltzmann function.
Expression and Purification with COS7 Cells—Kv4.2* was co-ex-
pressed with KChIP2 in COS7 cells using LipofectAMINE 2000 (In-
vitrogen, Carlsbad, CA) and 2.5 and 5 g cDNA/plate, respectively.
10–25 100 mm plates were harvested 2 days after transfection and
solubilized for 1 h at 4 °C in lysis buffer containing 2.5% CHAPS, 100
mM NaCl, 40 mM KCl, 1.0 mg/ml Escherichia coli lipid, 1 mM dithio-
threitol, 0.2 mM leupeptin/pepstatin, 1 mM EDTA, 20 mM HEPES-KOH,
pH 7.4, and 10% glycerol with Complete protease inhibitors (Roche
Applied Science). Soluble material (SM) was collected after centrifuga-
tion at 100,000  g for 45 min. The extract was incubated with anti-
1D4-coated beads for 2 h at 4 °C with agitation often between New
Haven, CT, and Waltham, MA (Honda Civic 1999). The column was
washed with 50 ml of wash buffer containing 0.7% CHAPS, 300 mM
NaCl, 40 mM KCl, 0.01 mM leupeptin/pepstatin, 1 mM EDTA, 20 mM
HEPES-KOH, pH 7.4 with Complete protease inhibitors (Roche Applied
Science). Protein was then eluted (E) in wash buffer with 100 mM NaCl
and 0.2 mg/ml 1D4 peptide (Yale University Keck Facility). 1D4 mono-
clonal antibody was purchased (NCCC, Minneapolis MN) and coupled
to beads as before (21). KChIP2 antibodies were a generous gift (J.
Trimmer, University of California, Davis).
Whole-cell CTX Binding—3H-CTX binding to cells was performed as
described previously (22). Briefly, cell samples were divided into control
and test groups. Control assessed nonspecific binding of 3H-CTX (36 nM)
that took place in the presence of 1 M non-radioactive CTX. Test
groups measured total 3H-CTX binding and specific binding was deter-
mined by subtracting the nonspecific from the total binding. All steps
were performed at 4 °C. Cells were exposed to 3H-CTX in binding buffer
(20 mM KCl, 10 mM NaPi, 100 mM sucrose, and 1 mg/ml bovine serum
albumin) for 30 min, collected by centrifugation for 1 min at 3,000 rpm,
and the supernatant was removed. The cell pellet was washed in 100 l
binding buffer, centrifuged, and after removal of supernatant, sus-
pended in 100 l of buffer, transferred to a scintillation vial with 10 ml
of scintillation fluid (SafeScint, American Bioanalytical, Natick, MA)
for liquid scintillation counting.
CTX Binding to Purified Complexes—A 50 l elution of purified
material was exposed to 36 nM 3H-CTX with or without 1 M unlabelled
CTX. As above, the two samples were used to assess nonspecific and
total binding of 3H-CTX. Binding was performed at 4 °C for 30 min,
8 h, 16 h, or 24 h, after which unbound toxin was removed with an
Amicon Centricon 100 (Millipore, Billerica, MA) by centrifugation for
10 s at 9,000 rpm and a wash with 20 l wash buffer with only 100 mM
NaCl by centrifugation. The filter was then placed in a liquid scintilla-
tion vial and studied in a scintillation counter as above. The dose-
titration assay was performed in a similar manner with 25 l aliquots
of purified channel complex. 0, 0.45, 1.33, 4, 12, or 36 nM 3H-CTX was
applied to a control and test sample for 30 min at 4 °C and processed as
above.
Glycerol Gradient Analysis—Kv4.2*KChIP2 protein complex (0.5
ml, 2 g, E2–4) was layered on a 12 ml 10–40% (w/v) linear glycerol
gradient containing 0.7% CHAPS, 100 mM NaCl, 40 mM KCl, 1 mM
EDTA, 20 mM HEPES-KOH, pH 7.4, and Complete protease inhibitors
(Roche Applied Science). A parallel gradient was layered with 20 g of
each of the following molecular mass markers (Amersham Biosciences);
chymotrypsinogen (25 kDa), albumin (67 kDa), aldolase (158 kDa),
catalase (232 kDa), and ferritin (440 kDa). Gradients were centrifuged
for 15 h at 35,000 rpm and 4 °C using an SW41 rotor (Beckman,
Fullerton, CA). 1-ml fractions were collected by upward displacement.
Proteins were precipitated with 5 volumes acetone at 20 °C for
analysis.
Amino Acid Analysis—After SDS-PAGE and staining with Coomas-
FIG. 1. A CTX-sensitive variant of Kv4.2. a, alignment of the pore
loop region of human Kv4.2 (residues 343–385 shown) and the toxin-
sensitive mutant (Kv4.2*); changes reproduce residues in Kv1.3. b,
wild-type Kv4.2 (open square) and Kv4.2KChIP2 channels (filled
square) are insensitive to CTX (arrows), 15 and 45 nM applied, respec-
tively. Kv4.2* (open circle) and Kv4.2*KChIP2 channels (filled circles)
are blocked by 1.67 nM CTX (arrows). Channels expressed in oocytes
studied by two-electrode voltage clamp with depolarization from 100
to 40 mV for 500 ms every 20 s (see “Materials and Methods”). c, CTX
block of channels formed by Kv4.2* (open circles) and Kv4.2*KChIP2
(filled circles). Data represents unblocked fractional current as a func-
tion of CTX concentration and is fit to: fu  (1  ([CTX]/Ki)
h)1. Fits
yield Ki  0.35  0.04 and 0.76  0.03, with coefficients h  0.89 and
1.02, respectively. Each point is mean  S.E. for 3–10 oocytes.
TABLE I
Channel gating parameters for Kv4.2 and Kv4.2* channels with and without KChIP2
Parameters for Kv4.2 and Kv4.2* expressed alone or with KChIP2 from measurements by two electrode voltage clamp using oocytes as described
under ‘‘Materials and Methods.’’ V0.5 and Vs were calculated by fitting the conductance-voltage and normalized current-voltage relationships,
respectively, to a Boltzmann function. Inactivation kinetics were fit to a double exponential function. Recovery kinetics were fit to a
single exponential.
Kv4.2 Kv4.2KChIP2 Kv4.2* Kv4.2*KChIP2
Activation V0.5 (mV) 24.3  0.6 26.8  0.9 28.9  1.0 30.2  0.9
Activation Vs (mV) 13.7  0.3 10.3  0.2 12.0  0.3 8.5  0.1
Vpeak at 40 mV (A) 1.5  0.1 4.9  0.4 2.2  0.3 4.9  0.6
Inactivation V0.5 (mV) 62.2  0.8 50.3  1.0 58.6  0.6 52.5  0.4
Inactivation Vs (mV) 6.1  0.2 3.50  0.03 6.6  0.2 3.20  0.02
Inactivation slow (ms) 204  20 197  15 140  21 172  9
Inactivation fast (ms) 30.5  4.2 62.4  4.7 21.8  2.0 22.4  3.3
Aslow/(AslowAfast) 0.17 0.48 0.20 0.48
Afast/(AslowAfast) 0.83 0.52 0.80 0.52
Recovery rec 192  8 19.3  0.6 221  8 24.5  1.5
n (no. of oocytes) 5 5–8 5–6 5–11
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sie Brilliant Blue, bands corresponding to Kv4.2* and KChIP2 and a
blank portion of the gel were excised with a sterile scalpel. Samples
were hydrolyzed in 6 N HCl and 0.2% phenol for 16 h at 115 °C with 2
nmol norleucine/100 l HCl as an internal standard. After hydrolysis,
amino acids were quantified on a Beckman 7300 Amino Acid Analyzer
via ion-exchange and post-column ninhydrin detection (Yale University
Keck Facility). After quantification, some amino acids are not analyzed
due to intrinsic limitations of the method: these include His, which
co-elutes with Tris in the SDS-PAGE buffer, Gly, which is in SDS-
PAGE buffer, and Arg, which is variably obscured by ammonia in gel
samples. Amino acids residues determined for the blank gel sample
were subtracted from subunit samples to correct for background signal.
9–12 amino acids for each subunit were observed to be within 10% of
predicted value in each trial and were studied: Asn, Asp, Thr, Gln, Glu,
Pro, Ala, Val, Ile, Leu, Phe, and Lys.
RESULTS
First, a variant of human Kv4.2 -subunits (Kv4.2*) was
produced that maintained the functional attributes of wild-
type but had two modifications, a pore binding site for the
peptide toxin CTX and an 8 residue C-terminal epitope tag
(1D4, ETSQVADA). The rationale for these embellishments
was as follows. A single CTX molecule binds in the ion conduc-
tion pore of toxin-sensitive K channels to occlude the perme-
ation pathway only when 4 permissive -subunits are assem-
bled in correct fashion; as a result, small changes in pore (or
toxin) structure are registered with great sensitivity as altered
blockade (23–25). Thus, CTX and related toxins were used to
locate the external aspect of the conduction pore (26), assess its
dimensions (27, 28), count channels (22), and, as here, assess
the integrity of purified channel protein (19). The 1D4 epitope
allows purification of membrane proteins under mild condi-
tions via monoclonal antibody binding and peptide elution (21).
The CTX-sensitive variant of Kv4.2 was produced by intro-
duction of 3 mutations in the pore loop (Fig. 1a) chosen in an
iterative fashion based on residues found to be important for
high-affinity toxin binding in other K channels (29, 30). Al-
though wild-type Kv4.2 channels are insensitive to application
of CTX, those with Kv4.2* -subunits show half-maximal block
(Ki) at 0.35  0.04 nM (Fig. 1, b and c). Similarly, wild-type
Kv4.2KChIP2 channels are insensitive to toxin whereas those
with Kv4.2* -subunits showed Ki  0.76  0.03 nM (Fig. 1, b
and c). As CTX is external and KChIP2 subunits are intracel-
lular, the increase in Ki observed on KChIP2 incorporation was
unexpected. Relaxation to equilibrium blockade upon acute
toxin application revealed KChIP2 to have little effect on the
toxin on-rate (Kon  18.1  1.4 M
1 s1 versus Kon  24.5 
2.3 M1 s1 with KChIP2, n  8–10) but to destabilize bound
toxin, increasing its off-rate 3-fold (Koff  8.0  0.6  10
3
s1 versus Koff  22.9  2.6  10
3 s1). This indicates small
KChIP2-induced changes in the external pore of the closed
channel (the predominant state in this protocol).
Despite modifications to confer CTX sensitivity and append
FIG. 2. KChIP2 has similar effects on Kv4.2 and the CTX-sensitive variant Kv4.2*. Channels expressed in oocytes and studied by
two-electrode voltage clamp (see “Materials and Methods”); determined gating parameters in Table I. Symbols for each channel type are as in Fig.
1b: wild-type Kv4.2 (open square); Kv4.2KChIP2 channels (filled square); Kv4.2* (open circle) and Kv4.2*KChIP2 channels (filled circles). a,
currents evoked by depolarizing from a holding potential of 100 mV to test potentials of 80 to 70 mV in 10 mV steps lasting 500 ms every 5 s.
b, current-voltage relationship shows 2–3-fold increase in current density with KChIP2. c, conductance-voltage relationship shows hyperpolarizing
shift with KChIP2. d, inactivation-voltage relationship shows right shift in steady state inactivation with KChIP2. e, recovery from inactivation
reveals a 10-fold increase in the rate of recovery with KChIP2.
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the epitope tag, channels with Kv4.2* behaved almost like
those with wild-type subunits (Table I and Fig. 2). Kv4.2*
channels are like wild-type in their voltage-dependence for
half-maximal activation and half-maximal steady state inacti-
vation. Although small differences in inactivation kinetics were
observed for slow (slow) and fast (fast) time constants, these
were without associated changes in their relative ratio, or rates
of recovery from inactivation. Moreover, the archetypal effects
of KChIP2 were unaltered by the -subunit mutations. Thus,
KChIP2 produced similar increases in current density and
rates of recovery from inactivation with both wild type Kv4.2
and Kv4.2*, and similar decreases in rates of inactivation (due
to increased contribution of the slow component) with expected
small shifts in the voltage required to achieve half-maximal
activation and half-maximal steady state inactivation.
Radioactive CTX (3H-CTX) was synthesized as previously
reported (22) and used first to monitor and optimize surface
expression of channels on COS7 cells (see “Materials and Meth-
ods”). As expected based on measurement of channel currents,
KChIP2 increased the absolute number of channels on the cells
2.6-fold, from 1.6  0.2 pmol/plate (n  4) to 4.0  0.2
pmol/plate (n  11). Purification of Kv4.2*KChIP2 complexes
was achieved via the 1D4 epitope on Kv4.2* with anti-1D4
antibodies covalently bound to beads (Fig. 3). Thus, COS7 cells
induced to transiently express Kv4.2* and KChIP2 at high
levels were solubilized with the detergent CHAPS (2.5%), and
complexes isolated by binding, washing with buffer, and elu-
tion with 1D4 peptide (see “Materials and Methods”). This led
to co-purification of Kv4.2* and KChIP2 (Fig. 3, a–c). Western
blot analysis revealed excess KChIP2 in soluble material (SM)
and unbound flow though (FT) whereas Kv4.2*KChIP2 chan-
nels were enriched in fractions collected by peptide elution (E)
(Fig. 3a). Staining with Coomassie Blue confirmed the E2 frac-
tion to be rich in the two channel subunits (Fig. 3b).
Purified material was subjected to centrifugation through a
glycerol gradient and studied by Western blot analysis after
SDS-PAGE to estimate the size of Kv4.2*KChIP2 channels.
The complex had a molecular mass between 232–440 kDa in
trials with four separate preparations (Fig. 3c). Because Kv4.2*
subunits carry no carbohydrate, each 642 residue protein has a
predicted mass of 72 kDa and each tetramer a mass of 288
kDa (an underestimate due to detergent binding (21)). Because
KChIP2 has 252 residues and a predicted mass of28 kDa this
result argues that complexes contain between 1 and 6 KChIP2
subunits (316–456 kDa). The predicted mass for an oc-
tameric complex with 4 Kv4.2* subunits and 4 KChIP2 sub-
units is 400 kDa.
To verify the stability and integrity of purified Kv4.2*
KChIP2 channels over time, binding of 3H-CTX to isolated
complexes was assessed. After 24 h at 4 °C, 90% of the bind-
ing activity was retained (Fig. 4a). Indeed, despite residence in
detergent rather than a lipid membrane, purified complexes
bound 3H-CTX with high affinity. Binding studies with four
separate preparations Kv4.2*KChIP2 were well fit to a single-
site binding (Langmuir) isotherm with a Kd 4.8 nM (Fig. 4b).
Because CTX binding occurs with high affinity only when pores
are properly assembled, the results provide direct evidence
that the isolated complexes are a good approximation of the
channels in plasma membranes and indicate their homogeneity
because a single high affinity toxin site is apparent.
To accurately assess the subunit composition of purified
Kv4.2*KChIP2 complexes, the two subunits were separated by
SDS-PAGE, identified by staining with Coomassie Brilliant
FIG. 3. Purification of Kv4.2*KChIP2 complexes and estima-
tion of mass by glycerol gradient centrifugation. a, purified
Kv4.2*-KChIP2 channels separated by 10% SDS-PAGE, transferred to
nitrocellulose, and probed with anti-1D4 and anti-KChIP2 antibodies.
SM, soluble material from COS7 cell lysate. FT, flow through material
that did not bind to the anti-1D4 antibody-coated beads. E3 and E4,
peptide elution fractions 3 and 4. b, E2 fraction separated by SDS-
PAGE and stained with Coomassie Brilliant Blue. The bands corre-
sponding to each subunit were excised and subjected to amino acid
analysis (Table II). The band with a star is a minor contaminant (1%)
of 1D4 purifications (21). c, E2 fraction applied to a 10–40% glycerol
gradient subjected to centrifugation and examined by 10% SDS-PAGE
and Western blot analysis with anti-1D4 and anti-KChIP2 antibodies.
Peak fractions for Kv4.2*KChIP2 complexes are between markers at
232 and 440 kDa (catalase and ferritin, respectively).
FIG. 4. 3H-CTX binding reveals stability and integrity of puri-
fied Kv4.2*KChIP2 complexes. a, 3H-CTX binding to Kv4.2*KChIP2
complexes at various times after isolation: 30 min, 8 h, 16 h, and 24 h
(n  3), as in “Materials and Methods.” b, 3H-CTX binding to
Kv4.2*KChIP2 complexes with increasing 3H-CTX (0, 0.45, 1.33, 4, 12,
or 36 nM) and fit to a single-site function reveals Kd 4.8 nM (n  4), as
in “Materials and Methods.”
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Blue dye, and the bands excised from the gel for amino acid
analysis by hydrolysis, ion-exchange chromatography, and nin-
hydrin detection (Table II). Because the amino acid sequences
of Kv4.2* and KChIP2 were known, the expected and observed
amino acid content of the bands could be compared and the
moles of each subunit determined independently from 9–12
residues in each of 3 independent trials. The molar ratio of
Kv4.2*:KChIP2 in purified complexes was 1:1 (Table II); simi-
lar results are noted in a companion report for channels with a
KChIP2 variant and others with a Kv4.2* mutant.2 Purified
channels are shown to have 4 -subunits because CTX binds
with high affinity (Fig. 4). A 1:1 molar ratio therefore indicates
that Kv4.2*KChIP2 complexes contain 4 KChIP2 subunits.
DISCUSSION
Accessory -subunits are a fundamental feature of K chan-
nels that determine channel location, abundance, sensitivity to
stimulation, and pharmacology in vivo (6, 20, 32). Here we
demonstrate that regulatory KChIP2 subunits assemble with
pore-forming Kv4.2 subunits in 4:4 complexes when over-ex-
pressed in tissue culture cells to produce voltage-gated K
channels like those in native cells (such as cardiac Ito (3, 4)). A
4:4 subunit arrangement appears to be the natural and stable
valence for Kv4.2*KChIP2 channels first because it was found
with four separate large-scale preparations and second because
KChIPs could not be separated from -subunits without com-
plete dissociation of the complexes to monomer form (not
shown). KChIP2 increases trafficking to the surface, channel
half-life, and detergent solubility of mixed complexes formed
with Kv4.2 (6). This suggests why we could purify significant
amounts of Kv4.2*KChIP2 channels but did not succeed when
Kv4.2* -subunits were expressed alone (not shown). We ex-
pect KChIPs and related neuronal calcium sensing proteins
(such as frequenin (16)) to assemble with other K channel
-subunits with 4:4 stoichiometry to yield similar effects on
stability, structure, and function.
A 4:4 subunit stoichiometry is also seen with the soluble
intracellular regulator Kv2 in assemblies with the N-terminal
segments of Kv1 -subunits (33). Similarly, KCNMB1-encoded
-subunits (two span transmembrane proteins) and voltage-
and calcium-gated BK -subunits assemble with 4:4 valence
(34, 35). The same subunit ratio is found with SUR -subunits
(bearing 17 predicted transmembrane segments) and Kir6.2
-subunits (36–38). In contrast, just 2 KCNE1-encoded MinK
-subunits (peptides with a single transmembrane span) as-
semble with 4 KCNQ1 -subunits to form cardiac IKs channels
(39, 40); a 2:4 ratio is therefore expected for other channels
with MinK-related peptides (MiRP1–4) (20). How many DPPX
monomers (another single span -subunit) assemble with Kv4
-subunits (41) is yet to be determined.
In a companion study,2 Kv4.2*KChIP2 complexes purified
by the strategy described here were found amenable to visual-
ization by negative stain electron microscopy; demonstration
here that isolated complexes maintain structural integrity and
have 4:4 subunit valence allowed three-dimensional images of
the channels to be reconstructed with a resolution of 21 Å.
KChIP2 incorporation was found to create an36 115 115
Å, intracellular fenestrated rotunda: 4 peripheral columns that
extend down from the membrane-embedded portion of the
channel to enclose the central Kv4.2 “hanging gondola” (a plat-
form held beneath the transmembrane conduction pore by 4
internal columns) (21, 31, 42, 43). To reach the pore from the
cytosol, ions pass through one of four external fenestrae to
enter the rotundal vestibule and then cross one of four internal
windows in the gondola. The location of KChIP2 subunits in the
structure is lateral to the gondola platform and does not over-
lap with the sub-platform locale for the Kv2 subunits appar-
ent in crystal structures (33). It is as yet unknown whether a
single channel complex can carry more than one type of acces-
sory subunit and if subunit stoichiometry is thereby varied.
These issues are under study by the methods described here.
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